wikimedia
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
Graphs
1
Q39137585-6F013D5C-2FA3-4874-9B87-552CCA340E85
Q39137585-6F013D5C-2FA3-4874-9B87-552CCA340E85
BestRank
Statement
http://www.wikidata.org/entity/statement/Q39137585-6F013D5C-2FA3-4874-9B87-552CCA340E85
Vandetanib combined with a p38 MAPK inhibitor synergistically reduces glioblastoma cell survival.
P2860
Q39137585-6F013D5C-2FA3-4874-9B87-552CCA340E85
BestRank
Statement
http://www.wikidata.org/entity/statement/Q39137585-6F013D5C-2FA3-4874-9B87-552CCA340E85
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
2a4edda388c50fc09c2753ddb3ba538269cc74b6
P2860
Phase I study of vandetanib with radiotherapy and temozolomide for newly diagnosed glioblastoma.